Use of selective serotonin reuptake inhibitors and risk of stroke: A systematic review and meta-analysis

Journal of Neurology

Volumn 261, Issue 4, 2014, Pages 686-695

  Shin, Doosup ^a,b   Oh, Yun Hwan ^a   Eom, Chun Sick ^c   Park, Sang Min ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Jangseong Public Health Center   (South Korea)

^c Hallym University   (South Korea)

Author keywords

Antidepressants; Meta analysis; Selective serotonin reuptake inhibitors; Stroke

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; ANTIDEPRESSANT AGENT;

ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DEPRESSION; EMBASE; HUMAN; MEDLINE; META ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; VASOCONSTRICTION; CHEMICALLY INDUCED; COMPLICATION; STROKE;

ANTIDEPRESSIVE AGENTS; DEPRESSION; HUMANS; RISK; SEROTONIN UPTAKE INHIBITORS; STROKE;

EID: 84898874411     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7251-9     Document Type: Article

References (37)

1. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR et al (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289:3095-3105 (Pubitemid 37432885)
2. Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB (2011) Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA 306:1241-1249
3. de Abajo FJ, Rodriguez LA, Montero D (1999) Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 319:1106-1109 (Pubitemid 29494721)
4. Skop BP, Brown TM (1996) Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics 37:12-16 (Pubitemid 26021814)
5. Hung CC, Lin CH, Lan TH, Chan CH (2013) The association of selective serotonin reuptake inhibitors use and stroke in geriatric population. Am J Geriatr Psychiatry 21:811-815
6. Singhal AB, Caviness VS, Begleiter AF, Mark EJ, Rordorf G, Koroshetz WJ (2002) Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology 58:130-133 (Pubitemid 34041951)
7. Trifiro G, Dieleman J, Sen EF, Gambassi G, Sturkenboom MC (2010) Risk of ischemic stroke associated with antidepressant drug use in elderly persons. J Clin Psychopharmacol 30:252-258
8. Hackam DG, Mrkobrada M (2012) Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis. Neurology 79:1862-1865
9. Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa(ON) Ottawa Hospital Research Institute; Available: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp (Accessed Aug 2013)
10. Bak S, Tsiropoulos I, Kjaersgaard JO, Andersen M, Mellerup E, Hallas J et al (2002) Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke 33:1465-1473 (Pubitemid 34619941)
11. Chen Y, Guo JJ, Li H, Wulsin L, Patel NC (2008) Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study. Ann Pharmacother 42:177-184 (Pubitemid 351238564)
12. Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J (2011) Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 343:d4551. doi: 10.1136/bmj.d4551
13. Pan A, Okereke OI, Sun Q, Logroscino G, Manson JE, Willett WC et al (2011) Depression and incident stroke in women. Stroke 42:2770-2775
14. Smoller JW, Allison M, Cochrane BB, Curb JD, Perlis RH, Robinson JG et al (2009) Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med 169:2128-2139
15. Douglas I, Smeeth L, Irvine D (2011) The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study. Br J Clin Pharmacol 71:116-120
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560 (Pubitemid 37088507)
17. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188 (Pubitemid 17189972)
18. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634 (Pubitemid 27387172)
19. Behr S, Andersohn F, Garbe E (2010) Risk of intracerebral hemorrhage associated with phenprocoumon exposure: a nested case-control study in a large population-based German database. Pharmacoepidemiol Drug Saf 19:722-730
20. de Abajo FJ, Jick H, Derby L, Jick S, Schmitz S (2000) Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol 50:43-47 (Pubitemid 30416970)
21. Kharofa J, Sekar P, Haverbusch M, Moomaw C, Flaherty M, Kissela B et al (2007) Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke 38:3049-3051 (Pubitemid 350035702)
22. Risselada R, Straatman H, van Kooten F, Dippel DW, van der Lugt A, Niessen WJ et al (2009) Withdrawal of statins and risk of subarachnoid hemorrhage. Stroke 40:2887-2892
23. Schalekamp T, Klungel OH, Souverein PC, De Boer A (2008) Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 168:180-185 (Pubitemid 351185885)
24. Verdel BM, Souverein PC, Meenks SD, Heerdink ER, Leufkens HGM, Egberts TCG (2011) Use of serotonergic drugs and the risk of bleeding. Clin Pharmacol Ther 89:89-96
25. Hauta-Aho M, Tirkkonen T, Vahlberg T, Laine K (2009) The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients. Ann Med 41:619-628
26. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V (2009) Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 8:355-369
27. Olfson MMSC (2009) NAtional patterns in antidepressant medication treatment. Arch Gen Psychiatry 66:848-856
28. Jakovljevic D, Tuomilehto J (2002) Use of selective serotonin reuptake inhibitors and the risk of stroke: is there reason for concern? Stroke 33:1448-1449 (Pubitemid 34619931)
29. Muhonen MG, Robertson SC, Gerdes JS, Loftus CM (1997) Effects of serotonin on cerebral circulation after middle cerebral artery occlusion. J Neurosurg 87:301-306 (Pubitemid 27349118)
30. Wu CS, Wang SC, Cheng YC, Gau SS (2011) Association of cerebrovascular events with antidepressant use: a case-crossover study. Am J Psychiatry 168:511-521
31. Robinson RG, Spalletta G (2010) Poststroke depression: a review. Can J Psychiatry 55:341-349
32. Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C et al (2011) Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 10:123-130
33. Mikami K, Jorge RE, Adams HP Jr, Davis PH, Leira EC, Jang M et al (2011) Effect of antidepressants on the course of disability following stroke. Am J Geriatr Psychiatry 19:1007-1015
34. Jorge RE, Acion L, Moser D, Adams HP Jr, Robinson RG (2010) Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 67:187-196
35. Mortensen JK, Larsson H, Johnsen SP, Andersen G (2013) Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: a nationwide propensity score-matched follow-up study. Stroke 44:420-426
36. Stegmayr B, Vinogradova T, Malyutina S, Peltonen M, Nikitin Y, Asplund K (2000) Widening gap of stroke between east and west. Eight-year trends in occurrence and risk factors in Russia and Sweden. Stroke 31:2-8 (Pubitemid 30035744)
37. Kinlay S (2011) Changes in stroke epidemiology, prevention, and treatment. Circulation 124:e494-e496